AtriCure, Inc.

NASDAQ:ATRC

Medical - Instruments & Supplies

Healthcare
$55.45 +3.52%

+$0.96 today

Market cap
$2.82B
Beta
1.26
P/E (TTM)
-295.5
EPS (TTM)
-$0.10
52W Low $25.36High $43.18

Volume 0.60M

Average 0.77M

ATRC Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

AtriCure, Inc.NASDAQ: ATRC

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 48.5M shares rose 2.0% year over year, in line with the +1.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.3% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2.0% holds above the trailing-twelve-month pace of +1.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
48.5M+0.3% QoQ
Last fiscal yearDec 2025
47.75M+1.7% YoY
LTMJun 2026
48.12M+1.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.0%——
1 year+1.7%——
3-year CAGR+1.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
47.75M USD
Year-over-year change
+1.7%
4-year CAGR
+1.5%

Weighted Avg Shares vs competitors

How ATRC compares with its peers on the latest reported figures

  • ATRC's LTM Jun 2026 weighted avg shares of 48.12M shares is the lowest of the 5 companies compared; the peer median is 930.78M shares.
  • Its year-over-year change of +1.8% is the highest of 5, against a peer median of +0.2%.
  • Over three fiscal years its annual growth of +1.4% compares with a peer median of -0.3%.
ATRC Competitors Peer median
Weighted Avg Shares for ATRC and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.48B +0.4%+1.1%
MDTMedtronic plcLTM Jul 20261.28B -0.1%-1.2%
EWEdwards Lifesciences CorporationLTM Jun 2026580.18M -1.7%-1.9%
LIVNLivaNova PLCLTM Sep 202654.83M +0.6%+0.6%
ATRCAtriCure, Inc.LTM Jun 202648.12M +1.8%+1.4%
Peer median (excluding ATRC) 930.78M+0.2%-0.3%

Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue274.33M330.38M399.25M465.31M534.53M
Cost of Revenue68.47M84.44M98.88M117.78M136.79M
Gross Profit205.86M245.94M300.37M347.52M397.74M
Gross Margin75.0%74.4%75.2%74.7%74.4%
Research & Development48.51M57.34M73.92M96.18M90.17M
Selling, General & Admin204.65M231.27M253.14M291.36M311.02M
Operating Expenses150.66M288.61M327.05M387.54M401.19M
Depreciation & Amortization10.44M11.71M14.81M18.73M20.53M
EBITDA65.75M(29.5M)(8.11M)(18.53M)16.25M
EBITDA Margin24.0%-8.9%-2.0%-4.0%3.0%
Operating Income55.21M(42.67M)(26.68M)(40.01M)(3.45M)
Operating Margin20.1%-12.9%-6.7%-8.6%-0.6%
Interest Income466K1.99M3.79M4.43M4.48M
Interest Expense4.92M4.99M6.93M6.41M5.88M
Other Income / Expenses(4.82M)(3.53M)(3.16M)(3.66M)(6.72M)
Income Before Tax50.39M(46.2M)(29.85M)(43.67M)(10.16M)
Pre-Tax Margin18.4%-14.0%-7.5%-9.4%-1.9%
Income Tax Expense188K268K591K1.02M1.29M
Net Income50.2M(46.47M)(30.44M)(44.7M)(11.45M)
Net Margin18.3%-14.1%-7.6%-9.6%-2.1%
EPS (Basic)1.11(1.02)(0.66)(0.95)(0.24)
EPS (Diluted)1.09(1.02)(0.66)(0.95)(0.24)
Weighted Avg Shares45.07M45.74M46.31M46.97M47.75M
Weighted Avg Shares (Diluted)46.04M45.74M46.31M46.97M47.75M

AtriCure, Inc.

NASDAQ:ATRC

Intrinsic Alpha fair value

Locked

Current Price

$55.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.